Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The purpose of this study is to test feasibility of measuring flumazenil-induced changes in cortical GABA levels observed with localized 1H-MRS in relation to changes in severity of hepatic encephalopathy (HE) in subjects with non-alcoholic liver cirrhosis. This study is a double-blind, placebo-controlled, randomized, cross-over design.
Epistemonikos ID: 3ff0616ef7e928561fa4d4995030d8323cde3cd0
First added on: Nov 24, 2021